Research programme: encapsulated cellular cancer immunotherapeutics - MaxiVaxAlternative Names: Encapsulated cellular cancer immunotherapy - MaxiVax
Latest Information Update: 10 Feb 2016
At a glance
- Originator MaxiVax
- Class Cancer vaccines; Cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 09 Feb 2016 Early research in Cancer in Switzerland (Parenteral)